Commodore Capital LP 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:42 pm Sale | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,802,905 1.800% | -7,405,155 (-72.54%) | Filing |
| 2025-11-14 4:57 pm Purchase | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 10,208,060 7.200% | 3,800,000 (+59.30%) | Filing |
| 2025-08-14 5:07 pm Purchase | 2025-07-07 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 6,408,060 5.500% | 1,138,836 (+21.61%) | Filing |
| 2025-08-14 5:05 pm Sale | 2025-06-30 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 5,269,224 4.600% | -5,228,766 (-49.81%) | Filing |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 10,497,990 9.300% | 4,325,904 (+70.09%) | Filing |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 6,172,086 7.100% | 1,246,086 (+25.30%) | Filing |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 4,926,000 7.000% | 2,644,685 (+115.93%) | Filing |
| 2022-02-14 4:07 pm Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,281,315 5.700% | 139,976 (+6.54%) | Filing |
| 2021-11-03 5:31 pm Purchase | 2021-10-07 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,141,339 5.400% | 2,141,339 (New Position) | Filing |